The number of
colorectal cancer (CRC) patients has been increasing rapidly worldwide in
recent decades, and the survival rates of CRC patients have increased in the
past few years, possibly as a result of progress in diagnostic faculty and
improved chemotherapy. The aim of this study was investigating the predictive potential of
these available and convenient laboratory dates in stage IV colorectal cancer
(CRC) patients.
The authors
identified the cases of 114 consecutive patients who underwent the surgery at
our Hospital between January 2006 and December 2012 by using the multivariate
analysis, the Cox proportional-hazard regression model. They divided the
patients in 3 groups: 1) metastatic lesion resection group with primary lesion
resection (n = 52 in the Met/Prim lesion group), 2) primary lesion resection
without metastatic lesion resection (n = 38 in the Primary lesion group) and 3)
palliative operation (n = 24 in the Palliative group). Routine
laboratory measurements prior to surgery were also analyzed in this study. And the
correlation between overall survival and clinicopathological findings,
including GPS, NLR and other general laboratory measurements in the Met/Prim
lesion group, was examined.
Multivariate
analysis for the predictors of survival showed metastatic lesion resection
[hazard ratio (HR) = 3.2, 95% confidence interval (CI) 1.6 - 6.6; p = 0.007]
and only primary lesion resection (HR = 1.9, 95% CI 1.1 - 4.0; p = 0.045)
remained independently significant prognostic factors. Age was the only
independent risk factor in the Met/Prim lesion group. In the Primary lesion
group, Neutrophil lymphocyte ratio (NLR) > 5, elevated Alanine
aminotransferase and patients without chemotherapy were correlated with poor
survival. In the Palliative group, NLR > 5 and patients who could not be
treated with chemotherapy remained independent predictors of worse survival.
In summary, the
adoption of the pretreatment measurement of the NLR is not only simple and
convenient for the classification of patients, but also one of the important
predictors of mortality for incurable stage IV CRC patients. Further study is required to test the validity, reliability,
reproducibility and clinical usefulness of the results for patients with stage
IV CRC.
Article by Shinya Munakata, et al, from
Juntendo University, Tokyo, Japan.
Full access: http://mrw.so/10BPc3
Image by Adrian Dan, from Flickr-cc.
评论
发表评论